EDIT Past Earnings image   This EDIT past earnings page last updated 5/17/2024
EDIT Past Earnings
PeriodPast Earnings DateGAAP
Q1 20245/8/2024-0.760
Q4 20232/28/2024-0.230
Q3 202311/3/2023-0.550
Q2 20238/2/2023-0.560
Q1 20235/5/2023-0.710
Q4 20222/22/2023-0.880
Q3 202211/2/2022-0.810
Q2 20228/3/2022-0.780
Q1 20225/4/2022-0.740
Q4 20212/24/2022-0.610
Q3 202111/8/2021-0.570
Q2 20218/4/2021-0.810
Q1 20215/5/2021-0.860
Q4 20202/25/2021-1.000
Q3 202011/5/20200.120
Q2 20208/6/2020-0.430
Q1 20205/7/2020-0.690
Q4 20192/26/2020-0.740
Q3 201911/12/2019-0.660
Q2 20198/6/2019-0.690
Q1 20195/7/2019-0.600
Q4 20182/28/2019-0.52
Q3 201811/7/2018-0.32
Q2 20188/6/2018-0.82
Q1 20185/3/2018-0.67
Q4 20173/6/2018-0.84
Q3 201711/7/2017-0.64
Q2 20178/9/2017-0.65
Q1 20175/15/2017-0.85
Q4 20163/7/2017-1.1
Q3 201611/7/2016-0.59
Q2 20168/9/2016-0.54
Q1 20165/16/2016-0.8
Q4 20153/30/2016-4.05
EDIT Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/8/20240.00B
Q4 20232/28/20240.06B
Q3 202311/3/20230.01B
Q2 20238/2/20230.00B
Q1 20235/5/20230.01B
Q4 20222/22/20230.01B
Q3 202211/2/20220.04M
Q2 20228/3/20220.01B
Q1 20225/4/20220.01B
Q4 20212/24/20220.01B
Q3 202111/8/20210.01B
Q2 20218/4/20210.00B
Q1 20215/5/20210.01B
Q4 20202/25/20210.01B
Q3 202011/5/20200.06B
Q2 20208/6/20200.01B
Q1 20205/7/20200.01B
Q4 20192/26/20200.01B
Q3 201911/12/20190.00B
Q2 20198/6/20190.00B
Q1 20195/7/20190.00B
Q4 20182/28/20196.12M
Q3 201811/7/201814.52M
Q2 20188/6/20187.37M
Q1 20185/3/20183.93M
Q4 20173/6/20183.67M
Q3 201711/7/20176.28M
Q2 20178/9/20173.10M
Q1 20175/15/2017682000
Q4 20163/7/2017898000
Q3 201611/7/2016962000
Q2 20168/9/20163.39M
Q1 20165/16/2016805000
Q4 20153/30/2016792000
Quotes delayed 20 minutes

Email EnvelopeFree EDIT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Editas Medicine (EDIT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

EGRX Past Earnings
EHAB Past Earnings
EHC Past Earnings
EIGR Past Earnings
EKSO Past Earnings
ELAN Past Earnings
ELDN Past Earnings
ELEV Past Earnings
ELOX Past Earnings
ELUT Past Earnings

EDIT Past Earnings Q&A

What was the best and worst EDIT past earnings results?
For Editas Medicine, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest EDIT past earnings result in our data set was 0.120/share posted in Q3 2020, while the lowest was in Q4 2015 when EDIT posted -4.05/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2020 when EDIT reported 0.06B in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at 0.04M of revenue.

  Suggested answer: There are 34 EDIT past earnings results in our data set.

On this page we presented the EDIT past earnings date information for Editas Medicine. Reviewing that EDIT Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2020, when EDIT posted gaap of 0.120/share. Meanwhile the lowest EDIT past earnings result was in Q4 2015, when EDIT posted gaap of -4.05/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2020 when EDIT reported 0.06B in revenue, while the smallest revenue quarter was Q3 2022 when EDIT reported 0.04M in revenue.

Any self directed investor doing their due diligence on EDIT or any other given stock can benefit from researching all of the Editas Medicine past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Editas Medicine past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for EDIT. Thanks for visiting, and the next time you need to research EDIT past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: AME Dividend History, Institutional Holders of ENSG, AZO Technical Analysis.


EDIT Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.